TWiV 1064: Clinical update with Dr. Daniel Griffin

<p>In his weekly clinical update, Dr. Griffin discusses progress toward measles elimination, risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune-suppressive drugs, symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals, late administration and corticosteroid usage explain inefficacy in COVID-19 convalescent plasma trial, higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19, recombinant C1 inhibitor in the prevention of severe COVID-19, and Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.</p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3 id="links-for-this-episode" class="wp-block-heading"> <strong>Links for this episode</strong></h3> <ul> <li><a href= "https://www.cdc.gov/mmwr/volumes/72/wr/mm7246a3.htm?s_cid=mm7246a3_w"> Progress</a> toward measles elimination (CDC)</li> <li>Risk of severe COVID-19 despite vaccination in patients using <a href= "https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.14168?campaign=wolearlyview">immune-suppressive drugs</a> (TID)</li> <li><a href= "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad696/7420299?utm_source=advanceaccess&utm_campaign=cid&utm_medium=email&nbd=40427954633&nbd_source=campaigner"> Symptoms, viral loads, and rebound</a> among COVID-19 outpatients treated with nirmatrelvir/ritonavir co